{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T03:23:43Z","timestamp":1769916223191,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-024-03849-8","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T07:43:25Z","timestamp":1732002205000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Associations of anaemia and iron deficiency with health-related quality of life in patients with chronic kidney disease stage G3b-5 in Japan: sub analysis of the Reach-J CKD cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Reiko","family":"Okubo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Ohigashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahide","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoya","family":"Tsunoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirayasu","family":"Kai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chie","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiei","family":"Narita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Yamagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,19]]},"reference":[{"key":"3849_CR1","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/nep.12493","volume":"20","author":"S Iimori","year":"2015","unstructured":"Iimori S, Naito S, Noda Y, Nishida H, Kihira H, Yui N, et al. Anaemia management and mortality risk in newly visiting patients with chronic kidney disease in Japan: The CKD-ROUTE study. Nephrology (Carlton). 2015;20:601\u20138.","journal-title":"Nephrology (Carlton)"},{"key":"3849_CR2","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/1744-9987.12712","volume":"22","author":"T Akizawa","year":"2018","unstructured":"Akizawa T, Okumura H, Alexandre AF, Fukushima A, Kiyabu G, Dorey J. Burden of anemia in chronic kidney disease patients in Japan: A literature review. Ther Apher Dial. 2018;22:444\u201356.","journal-title":"Ther Apher Dial"},{"key":"3849_CR3","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/ckj\/sfz091","volume":"13","author":"MMY Wong","year":"2020","unstructured":"Wong MMY, Tu C, Li Y, Perlman RL, Pecoits-Filho R, Lopes AA, et al. Anemia and iron deficiency among chronic kidney disease stages 3\u20135ND patients in the chronic kidney disease outcomes and practice patterns study: Often unmeasured, variably treated. Clin Kidney J. 2020;13:613\u201324.","journal-title":"Clin Kidney J"},{"key":"3849_CR4","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1681\/ASN.2019020213","volume":"31","author":"EK Batchelor","year":"2020","unstructured":"Batchelor EK, Kapitsinou P, Pergola PE, Kovesdy CP, Jalal DI. Iron deficiency in chronic kidney disease: Updates on pathophysiology, diagnosis, and treatment. J Am Soc Nephrol. 2020;31:456\u201368.","journal-title":"J Am Soc Nephrol"},{"key":"3849_CR5","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.kint.2021.03.020","volume":"99","author":"JL Babitt","year":"2021","unstructured":"Babitt JL, Eisenga MF, Haase VH, Kshirsagar AV, Levin A, Locatelli F, et al. Controversies in optimal anemia management: Conclusions from a kidney disease: Improving global outcomes (KDIGO) conference. Kidney Int, Conference Participants. 2021;99:1280\u201395.","journal-title":"Kidney Int, Conference Participants"},{"key":"3849_CR6","doi-asserted-by":"publisher","first-page":"e1223","DOI":"10.34067\/KID.0000000000000204","volume":"4","author":"T Kuragano","year":"2023","unstructured":"Kuragano T, Okami S, Tanaka-Mizuno S, Uenaka H, Kimura T, Ishida Y, et al. Anemia treatment, hemoglobin variability, and clinical events in patients with nondialysis-dependent CKD in Japan. Kidney360. 2023;4:e1223\u201335.","journal-title":"Kidney360"},{"key":"3849_CR7","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.kint.2019.04.029","volume":"96","author":"ME Cho","year":"2019","unstructured":"Cho ME, Hansen JL, Peters CB, Cheung AK, Greene T, Sauer BC. An increased mortality risk is associated with abnormal iron status in diabetic and non-diabetic veterans with predialysis chronic kidney disease. Kidney Int. 2019;96:750\u201360.","journal-title":"Kidney Int"},{"key":"3849_CR8","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1681\/ASN.2020101531","volume":"32","author":"M Guedes","year":"2021","unstructured":"Guedes M, Muenz DG, Zee J, Bieber B, Stengel B, Massy ZA, et al. Serum biomarkers of iron stores are associated with increased risk of all-cause mortality and cardiovascular events in nondialysis CKD patients, with or without anemia. J Am Soc Nephrol. 2021;32:2020\u201330.","journal-title":"J Am Soc Nephrol"},{"key":"3849_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/ndt\/gfz192","volume":"36","author":"AA Awan","year":"2021","unstructured":"Awan AA, Walther CP, Richardson PA, Shah M, Winkelmayer WC, Navaneethan SD. Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease. Nephrol Dial Transplant. 2021;36:129\u201336.","journal-title":"Nephrol Dial Transplant"},{"key":"3849_CR10","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1093\/ndt\/gfad096","volume":"38","author":"T Hasegawa","year":"2023","unstructured":"Hasegawa T, Imaizumi T, Hamano T, Murotani K, Fujii N, Komaba H, et al. Association between serum iron markers, iron supplementation and cardiovascular morbidity in pre-dialysis chronic kidney disease. Nephrol Dial Transplant. 2023;38:2713\u201322.","journal-title":"Nephrol Dial Transplant"},{"key":"3849_CR11","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1093\/ndt\/gfab050","volume":"36","author":"M Guedes","year":"2021","unstructured":"Guedes M, Muenz D, Zee J, Lopes MB, Waechter S, Stengel B, et al. Serum biomarkers of iron stores are associated with worse physical health-related quality of life in nondialysis-dependent chronic kidney disease patients with or without anemia. Nephrol Dial Transplant. 2021;36:1694\u2013703.","journal-title":"Nephrol Dial Transplant"},{"key":"3849_CR12","unstructured":"Kidney Int Suppl. 2012. https:\/\/kdigo.org\/wp-content\/uploads\/2016\/10\/KDIGO-2012-Anemia-Guideline-English.pdf."},{"key":"3849_CR13","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1093\/ndt\/gft033","volume":"28","author":"F Locatelli","year":"2013","unstructured":"Locatelli F, B\u00e1r\u00e1ny P, Covic A, De Francisco A, Del Vecchio L, Goldsmith D, et al. Kidney disease: Improving global outcomes guidelines on anaemia management in chronic kidney disease: A European renal best practice position statement. Nephrol Dial Transplant. 2013;28:1346\u201359.","journal-title":"Nephrol Dial Transplant"},{"key":"3849_CR14","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.kint.2023.05.009","volume":"104","author":"E Ku","year":"2023","unstructured":"Ku E, Del Vecchio L, Eckardt KU, Haase VH, Johansen KL, Nangaku M, et al. Novel anemia therapies in chronic kidney disease: Conclusions from a kidney disease: Improving global outcomes (KDIGO) controversies conference. Kidney Int, for Conference Participants. 2023;104:655\u201380.","journal-title":"Kidney Int, for Conference Participants"},{"key":"3849_CR15","doi-asserted-by":"crossref","unstructured":"2015. JSDT guideline for renal anemia in chronic kidney disease (in Japanese). J Jpn Soc Dial Ther 2016;49:89\u2013158.","DOI":"10.4009\/jsdt.49.89"},{"key":"3849_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10157-018-1648-1","volume":"23","author":"Japanese Society of Nephrology","year":"2019","unstructured":"Japanese Society of Nephrology. Essential points from evidence-based clinical practice guidelines for chronic kidney disease 2018. Clin Exp Nephrol. 2019;23:1\u201315.","journal-title":"Clin Exp Nephrol"},{"key":"3849_CR17","unstructured":"Japanese Society of Nephrology. Evidence-based clinical practice guideline for CKD 2023 (in Japanese). Tokyo-Igakusha. 2023."},{"key":"3849_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10157-017-1453-2","volume":"22","author":"J Hoshino","year":"2018","unstructured":"Hoshino J, Nagai K, Kai H, Saito C, Ito Y, Asahi K, et al. A nationwide prospective cohort study of patients with advanced chronic kidney disease in Japan: The reach-J CKD cohort study. Clin Exp Nephrol. 2018;22:309\u201317.","journal-title":"Clin Exp Nephrol"},{"key":"3849_CR19","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1007\/s10157-021-02059-y","volume":"25","author":"J Hoshino","year":"2021","unstructured":"Hoshino J, Tsunoda R, Nagai K, Kai H, Saito C, Ito Y, et al. Comparison of annual eGFR decline among primary kidney diseases in patients with CKD G3b\u20135: Results from a REACH-J CKD cohort study. Clin Exp Nephrol. 2021;25:902\u201310.","journal-title":"Clin Exp Nephrol"},{"key":"3849_CR20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1053\/j.ajkd.2016.03.414","volume":"68","author":"L Mariani","year":"2016","unstructured":"Mariani L, Stengel B, Combe C, Massy ZA, Reichel H, Fliser D, et al. The CKD outcomes and practice patterns study (CKDopps): Rationale and methods. Am J Kidney Dis. 2016;68:402\u201313.","journal-title":"Am J Kidney Dis"},{"key":"3849_CR21","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"JJ Ware","year":"1996","unstructured":"Ware JJ, Kosinski M, Keller SD. A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220\u201333.","journal-title":"Med Care"},{"key":"3849_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/BF00451725","volume":"3","author":"RD Hays","year":"1994","unstructured":"Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res. 1994;3:329\u201338.","journal-title":"Qual Life Res"},{"key":"3849_CR23","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/nep.13955","volume":"26","author":"R Okubo","year":"2021","unstructured":"Okubo R, Kondo M, Tsunoda R, Nagai K, Kai H, Saito C, et al. Physical functioning in patients with chronic kidney disease stage G3b\u20135 in Japan: The reach-J CKD cohort study. Nephrology (Carlton). 2021;26:981\u20137.","journal-title":"Nephrology (Carlton)"},{"key":"3849_CR24","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1053\/j.jrn.2019.11.003","volume":"30","author":"J Hoshino","year":"2020","unstructured":"Hoshino J, Muenz D, Zee J, Sukul N, Speyer E, Guedes M, et al. Associations of hemoglobin levels with health-related quality of life, physical activity, and clinical outcomes in persons with stage 3\u20135 nondialysis CKD. J Ren Nutr. 2020;30:404\u201314.","journal-title":"J Ren Nutr"},{"key":"3849_CR25","unstructured":"Kidney disease quality of life instrument (KDQOL). https:\/\/www.rand.org\/health-care\/surveys_tools\/kdqol.html."},{"key":"3849_CR26","first-page":"A118","volume":"3","author":"TD Topolski","year":"2006","unstructured":"Topolski TD, LoGerfo J, Patrick DL, Williams B, Walwick J, Patrick MB. The rapid assessment of physical activity (RAPA) among older adults. Prev Chronic Dis. 2006;3:A118.","journal-title":"Prev Chronic Dis"},{"key":"3849_CR27","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12882-020-01746-4","volume":"21","author":"H van Haalen","year":"2020","unstructured":"van Haalen H, Jackson J, Spinowitz B, Milligan G, Moon R. Impact of chronic kidney disease and anemia on health-related quality of life and work productivity: Analysis of multinational real-world data. BMC Nephrol. 2020;21:88.","journal-title":"BMC Nephrol"},{"key":"3849_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2215\/CJN.00630208","volume":"4","author":"FO Finkelstein","year":"2009","unstructured":"Finkelstein FO, Story K, Firanek C, Mendelssohn D, Barre P, Takano T, et al. Health-related quality of life and hemoglobin levels in chronic kidney disease patients. Clin J Am Soc Nephrol. 2009;4:33\u20138.","journal-title":"Clin J Am Soc Nephrol"},{"key":"3849_CR29","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1056\/NEJMoa065485","volume":"355","author":"AK Singh","year":"2006","unstructured":"Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006;355:2085\u201398.","journal-title":"N Engl J Med"},{"key":"3849_CR30","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.kint.2023.02.019","volume":"103","author":"KL Johansen","year":"2023","unstructured":"Johansen KL, Cobitz AR, Singh AK, Macdougall IC, Lopes RD, Obrador GT, et al. The ASCEND-NHQ randomized trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis chronic kidney disease. Kidney Int. 2023;103:1180\u201392.","journal-title":"Kidney Int"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03849-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03849-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03849-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T20:01:42Z","timestamp":1732046502000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-024-03849-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,19]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3849"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03849-8","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,19]]},"assertion":[{"value":"6 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Tsukuba Ethical Committee (approval number: H27-199). Informed consent was obtained from all participants included in this study. This study was also approved by the steering committee of the Reach-J CKD cohort study and was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors had conflicts of interest related to Mitsubishi Tanabe Pharma Corporation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"414"}}